Allergic Disease Onset Prevention Study

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

264

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

November 30, 2024

Study Completion Date

October 31, 2025

Conditions
Atopic DermatitisType 1 Hypersensitivity
Interventions
BIOLOGICAL

STMC-103H

STMC-103H is a live biotherapeutic product (LBP) containing a consortium of intestinal bacteria

BIOLOGICAL

Placebo

Powder containing excipients found in STMC-103H: magnesium stearate, mannitol and silicon dioxide.

Trial Locations (31)

2145

The Children's Hospital at Westmead, Westmead

3052

Murdoch Children's Research Institute, Parkville

3168

Monash Children's Hospital, Clayton

4101

Queensland Children's Hospital, South Brisbane

5000

The Women's and Children's Hospital, Adelaide

6150

Fiona Stanley Hospital, Murdoch

10016

NYU Langone Fink Children's, New York

10029

Mt. Sinai Jaffe Allergy Institute, New York

11021

Northwell Healthcare, Great Neck

14642

University of Rochester Medical Center, Rochester

21205

Johns Hopkins University School of Medicine, Baltimore

29486

Coastal Pediatrics Research, Summerville

29607

Tribe Clinical Research, Greenville

30329

Children's Healthcare of Atlanta, Atlanta

45229

Cincinnati Children's Hospital, Cincinnati

46202

Riley Children's Health at University of Indiana, Indianapolis

48104

University of Michigan Health, Ann Arbor

53792

Univ. of Wisconsin-Madison/Jackson Research Group, Madison

60611

Lurie Children's Hospital, Chicago

60637

University of Chicago Medicine, Chicago

72202

Arkansas Children's Research Institute, Little Rock

75235

UT Southwestern/Children's Health, Dallas

78723

Dell Medical School at UT Austin, Austin

80045

Children's Hospital Colorado, Aurora

85724

University of Arizona Health Sciences, Tucson

90095

UCLA Health, Los Angeles

92123

Rady Children's Hospital - San Diego, San Diego

94158

UCSF Benioff Children's Hospital, San Francisco

98115

Seattle Allergy and Asthma Research Institute, Seattle

02215

Boston Children's Hospital, Boston

00725

Centro de Neumologia Pediatrica, Caguas

All Listed Sponsors
lead

Siolta Therapeutics, Inc.

INDUSTRY